View in EDS

The implications of hormone treatment for cancer risk, screening and treatment in transgender individuals.

Saved in:
Bibliographic Details
Title: The implications of hormone treatment for cancer risk, screening and treatment in transgender individuals.
Authors: Berner AM; Barts Cancer Institute, Queen Mary University of London, United Kingdom; Gender Identity Clinic London, Tavistock and Portman NHS Trust, United Kingdom. Electronic address: alison.berner@nhs.net., Atkinson SE; St Bartholomew's Hospital, Barts Health NHS Trust, United Kingdom.
Source: Best practice & research. Clinical endocrinology & metabolism [Best Pract Res Clin Endocrinol Metab] 2024 Sep; Vol. 38 (5), pp. 101909. Date of Electronic Publication: 2024 Jun 26.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101120682 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1594 (Electronic) Linking ISSN: 1521690X NLM ISO Abbreviation: Best Pract Res Clin Endocrinol Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38964988
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The implications of hormone treatment for cancer risk, screening and treatment in transgender individuals.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Berner+AM%22">Berner AM</searchLink>; Barts Cancer Institute, Queen Mary University of London, United Kingdom; Gender Identity Clinic London, Tavistock and Portman NHS Trust, United Kingdom. Electronic address: alison.berner@nhs.net.<br /><searchLink fieldCode="AU" term="%22Atkinson+SE%22">Atkinson SE</searchLink>; St Bartholomew's Hospital, Barts Health NHS Trust, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101120682%22">Best practice & research. Clinical endocrinology & metabolism</searchLink> [Best Pract Res Clin Endocrinol Metab] 2024 Sep; Vol. 38 (5), pp. 101909. <i>Date of Electronic Publication: </i>2024 Jun 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101120682 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-1594 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221521690X%22">1521690X </searchLink><i>NLM ISO Abbreviation: </i>Best Pract Res Clin Endocrinol Metab <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38964988
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.beem.2024.101909
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101909
    Titles:
      – TitleFull: The implications of hormone treatment for cancer risk, screening and treatment in transgender individuals.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Berner AM
      – PersonEntity:
          Name:
            NameFull: Atkinson SE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2024 Sep
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1878-1594
          Numbering:
            – Type: volume
              Value: 38
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Best practice & research. Clinical endocrinology & metabolism
              Type: main
ResultId 1